Geoffrey M. Parker, a director at Perrigo Co. plc ($PRGO), bought shares on the open market four times in the last year, totaling about $402 thousand, with his latest purchase on November 12, 2025. These buys rank 997th among 4,983 insiders, below the average of $1.5 million per buyer. As CFO of Allogene Therapeutics, Inc. ($ALLO), he sold shares twice for $88 thousand total, most recently on February 2, 2026, ranking 9,752nd out of 11,678 insiders versus an average of $8.6 million in sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | A | Restricted Stock Units | 3024 | $0.00 | 3,024.0000 | 138,900,000 | 9999.99% | 0.00% |
| Feb. 2, 2026 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | S | Common Stock | 24001 | $1.76 | 1,252,795.0000 | 224,730,144 | 1.88% | 0.01% |
| Feb. 2, 2026 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Restricted Stock Unit | 152480 | $0.00 | 152,480.0000 | 224,730,144 | 9999.99% | 0.07% |
| Feb. 2, 2026 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to buy) | 539072 | $0.00 | 539,072.0000 | 224,730,144 | 9999.99% | 0.24% |
| Dec. 12, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | A | Restricted Stock Units | 2140 | $0.00 | 2,140.0000 | 138,900,000 | 9999.99% | 0.00% |
| Nov. 12, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | P | Ordinary Shares | 7500 | $14.18 | 72,166.0000 | 138,900,000 | 11.60% | 0.01% |
| Oct. 21, 2025 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | S | Common Stock | 36744 | $1.26 | 1,276,796.0000 | 217,264,738 | 2.80% | 0.02% |
| Sept. 12, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | A | Restricted Stock Units | 1263 | $0.00 | 1,263.0000 | 137,400,000 | 9999.99% | 0.00% |
| Aug. 18, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | P | Ordinary Shares | 4375 | $22.97 | 64,666.0000 | 137,400,000 | 7.26% | 0.00% |
| Aug. 18, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | P | Ordinary Shares | 4375 | $22.97 | 64,666.0000 | 137,400,000 | 7.26% | 0.00% |
| June 13, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | A | Restricted Stock Units | 976 | $0.00 | 976.0000 | 137,400,000 | 9999.99% | 0.00% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | M | Ordinary Shares | 9904 | $26.01 | 65,045.0000 | 137,400,000 | 17.96% | 0.01% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | F | Ordinary Shares | 4754 | $26.01 | 60,291.0000 | 137,400,000 | 7.31% | 0.00% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | M | Restricted Stock Units | 9904 | $0.00 | 0.0000 | 137,400,000 | 100.00% | 0.01% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | A | Restricted Stock Units | 7305 | $0.00 | 7,305.0000 | 137,400,000 | 9999.99% | 0.01% |
| May 12, 2025 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | P | Ordinary Shares | 3500 | $27.10 | 55,141.0000 | 137,400,000 | 6.78% | 0.00% |
| Feb. 3, 2025 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | S | Common Stock | 4361 | $1.73 | 1,301,540.0000 | 0 | 0.33% | 0.00% |
| Jan. 24, 2025 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Common Stock | 173913 | $0.00 | 1,305,901.0000 | 0 | 15.36% | 0.00% |
| Jan. 24, 2025 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to buy) | 614844 | $0.00 | 614,844.0000 | 0 | 9999.99% | 0.00% |
| Oct. 21, 2024 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | F | Common Stock | 36404 | $2.84 | 1,131,988.0000 | 0 | 3.12% | 0.00% |
| May 16, 2024 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Common Stock | 344828 | $2.90 | 1,164,418.0000 | 0 | 42.07% | 0.00% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | M | Restricted Stock Units | 8764 | $0.00 | 0.0000 | 135,300,000 | 100.00% | 0.01% |
| May 14, 2024 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | A | Restricted Stock Units | 9904 | $0.00 | 9,904.0000 | 135,300,000 | 9999.99% | 0.01% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | F | Ordinary Shares | 4207 | $30.22 | 20,262.0000 | 135,300,000 | 17.19% | 0.00% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | M | Ordinary Shares | 8764 | $30.22 | 24,469.0000 | 135,300,000 | 55.80% | 0.01% |
| Jan. 30, 2024 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | P | Common Stock | 190 | $3.60 | 819,590.0000 | 0 | 0.02% | 0.00% |
| Jan. 25, 2024 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to buy) | 103939 | $0.00 | 103,939.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2024 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Common Stock | 29400 | $0.00 | 819,400.0000 | 0 | 3.72% | 0.00% |
| Oct. 16, 2023 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 950000 | $0.00 | 950,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 16, 2023 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Common Stock | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 16, 2023 | Allogene Therapeutics, Inc. | $ALLO | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | A | Common Stock | 390000 | $0.00 | 790,000.0000 | 0 | 97.50% | 0.00% |
| June 13, 2023 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | P | Ordinary Shares | 10000 | $33.06 | 47,084.0000 | 134,500,000 | 26.97% | 0.01% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | F | Ordinary Shares | 3734 | $32.86 | 37,084.0000 | 134,500,000 | 9.15% | 0.00% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | M | Ordinary Shares | 7778 | $32.86 | 40,818.0000 | 134,500,000 | 23.54% | 0.01% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | M | Restricted Stock Units | 7778 | $0.00 | 0.0000 | 134,500,000 | 100.00% | 0.01% |
| May 15, 2023 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | A | Restricted Stock Units | 8764 | $0.00 | 8,764.0000 | 134,500,000 | 9999.99% | 0.01% |
| March 6, 2023 | PERRIGO Co plc | $PRGO | Parker Geoffrey M. | Director | P | Ordinary Shares | 5000 | $38.05 | 33,040.0000 | 134,500,000 | 17.83% | 0.00% |